GILEAD SCIENCES INC (GILD)
US3755581036 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 8.43B | 5.41B | 5.34B | 6.00B | 11.63B | |||
| Marketable Securities | 1.18B | 973.00M | 1.18B | 1.41B | 12.72B | |||
| Receivables | 4.66B | 4.78B | 4.49B | 4.89B | 3.58B | |||
| Inventories | 1.79B | 1.51B | 1.62B | 1.68B | 922.00M | |||
| Other Current Assets | 2.37B | 1.77B | 2.14B | 2.01B | 1.44B | |||
| Total Current Assets | 16.09B | 14.44B | 14.77B | 16.00B | 30.30B | |||
| Non-Current Assets | ||||||||
| PPE Net | 5.32B | 5.47B | 5.66B | 5.61B | 5.17B | |||
| Investments And Advances | 1.16B | 1.25B | 1.31B | 502.00M | 1.49B | |||
| Goodwill | 8.31B | 8.31B | 8.33B | 8.11B | 4.12B | |||
| Intangibles | 26.45B | 28.89B | 33.45B | 33.13B | 13.79B | |||
| Other Non-Current Assets | 4.79B | 4.80B | 4.42B | 5.06B | 6.77B | |||
| Total Non-Current Assets | 46.04B | 48.73B | 53.18B | 52.41B | 31.33B | |||
| TOTAL ASSETS | 62.13B | 63.17B | 67.95B | 68.41B | 61.63B | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 1.80B | 2.27B | 1.52B | 2.76B | 2.50B | |||
| Accrued Expenses | 7.72B | 7.10B | 7.60B | 7.20B | 6.25B | |||
| Accounts Payable | 550.00M | 905.00M | 705.00M | 844.00M | 713.00M | |||
| Other Current Liabilities | 1.21B | 959.00M | 1.79B | 598.00M | 293.00M | |||
| Total Current Liabilities | 11.28B | 11.24B | 11.61B | 11.40B | 9.76B | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 23.19B | 22.96B | 25.18B | 28.64B | 22.09B | |||
| Deferred Taxes/Income | 1.59B | 2.67B | 4.36B | N/A | N/A | |||
| Other Non-Current Liabilities | 3.32B | 5.09B | 5.74B | 10.14B | 7.12B | |||
| Total Non-Current Liabilities | 28.01B | 30.69B | 35.27B | 38.81B | 29.34B | |||
| TOTAL LIABILITIES | 39.29B | 41.93B | 46.88B | 50.20B | 39.10B | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | 16.30B | 15.69B | 16.32B | 14.38B | 19.39B | |||
| Additional Paid In Capital | 6.50B | 5.55B | 4.66B | 3.88B | 3.05B | |||
| Minority Interest | -32.00M | -5.00M | 19.00M | 53.00M | 147.00M | |||
| Common Shares | 1.00M | 1.00M | 1.00M | 1.00M | 1.00M | |||
| Other Shareholders' Equity | 33.00M | 35.00M | 87.00M | -62.00M | 84.00M | |||
| Shares Outstanding | 1.25B | 1.25B | 1.25B | 1.25B | 1.27B | |||
| Tangible Book Value per Share | -9.58 | -12.81 | -16.52 | -18.37 | 3.65 | |||
| Total Shareholders' Equity | 22.83B | 21.24B | 21.07B | 18.20B | 22.52B | |||
| TOTAL LIABILITIES AND EQUITY | 62.13B | 63.17B | 67.95B | 68.41B | 61.63B | |||
| Statistics | ||||||||
| Debt/Equity | 1.02 | 1.08 | 1.20 | 1.57 | 0.98 | |||
| Current Ratio | 1.43 | 1.29 | 1.27 | 1.40 | 3.10 | |||
| Return On Assets (ROA) | 9.12% | 7.27% | 9.16% | 0.18% | 8.74% | |||
| Return On Equity (ROE) | 24.81% | 21.62% | 29.55% | 0.68% | 23.91% | |||
| Return On Invested Capital (ROIC) | 12.90% | 15.48% | 14.11% | 5.73% | 6.89% | |||
| Return On Invested Capital Ex Cash (ROICexc) | 15.91% | 17.66% | 15.96% | 6.58% | 12.99% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | 101.39% | 96.41% | 98.97% | 39.01% | 37.19% | |||
All data in USD